Raymond March Archive

Raymond J. March is a Research Fellow at the Independent Institute and Assistant Professor of Economics at San José State University. His research examines the public and private provision and governance of healthcare in the United States, particularly in pharmaceutical markets.

If Telemedicine Is Underachieving, Government Is to Blame



Telemedicine providers have faced burdensome and complex regulatory structures at the state and federal level.

Putting Right-to-Try Drug Prices in Perspective



FDA regulation holds part of the blame for high drug prices.

EpiPen Pricing Controversy Reveals Ignorance about Market Competition



Increased competition is the remedy to skyrocketing drug prices.

Dear Congress, Please Don’t Keep Up with the Kardashians!



Kourtney Kardashian spoke on Capitol Hill in an attempt to motivate the federal government to play a larger role in regulating cosmetics. 

FDA Moves Closer to Approving Ecstasy



The FDA has granted MDMA breakthrough therapy status to expedite the approval process by making it easier for drugmakers to begin clinical trials.

Right-to-Try Law Signed!



On May 30, President Trump signed a bill into law allowing terminally ill patients access to potentially lifesaving drugs before they are approved by the Food and Drug Administration.

Curing Diseases Is Sustainable, Government in Healthcare Is Not



While Americans have every reason to be concerned about their healthcare, the belief that private medical companies will not develop and produce products that cure various conditions is unwarranted.

FDA Issues First Mandatory Recall for Contaminated Food



The U.S. Food and Drug Administration recently issued a mandatory recall for Triangle Pharmanaturals, a Las Vegas-based herbal supplements company.

FDA Restricts Sale of Contraceptive Device



The FDA released an order indicating its intent to restrict the sale of the contraceptive device Essure, the only FDA-approved nonsurgical permanent birth control method.

FDA Cracks Down on Online Eye-Exam Company



This past October, the Food and Drug Administration issued a warning letter to Opternative, a company specializing in providing online eye-exams.

  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org